Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,266 | 14,079 | 58,266 | 30,862 | 4,549 |
| Depreciation Amortization | 20,934 | 6,978 | 39,254 | 26,982 | 12,795 |
| Income taxes - deferred | 2,245 | 2,415 | 23,200 | 15,003 | 16,927 |
| Accounts receivable | 3,668 | -19,788 | -9,239 | -156 | 14,396 |
| Accounts payable and accrued liabilities | -71,798 | N/A | -2,129 | N/A | N/A |
| Other Working Capital | -73,446 | -86,173 | -279,027 | -272,792 | -48,222 |
| Other Operating Activity | 69,464 | 24,461 | 10,977 | 132 | -8,468 |
| Operating Cash Flow | $-37,667 | $-58,028 | $-158,698 | $-199,969 | $-8,023 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,528 | 36,863 | -66,670 | -52,734 | -42,015 |
| PPE Investments | -3,443 | -2,074 | -11,800 | -9,121 | -5,831 |
| Net Acquisitions | N/A | N/A | 7,407 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -99,275 | N/A | N/A |
| Purchase Sale Intangibles | -68 | -34 | -243 | -120 | -107 |
| Other Investing Activity | -68 | -34 | -243 | -120 | -107 |
| Investing Cash Flow | $-36,039 | $34,755 | $-170,581 | $-61,975 | $-47,953 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | N/A | -24,934 | -24,934 | -24,934 |
| Financing Cash Flow | $N/A | $N/A | $-24,934 | $-24,934 | $-24,934 |
| Exchange Rate Effect | -2,237 | -2,060 | 170 | -209 | -599 |
| Beginning Cash Position | 251,134 | 251,134 | 605,177 | 605,177 | 605,177 |
| End Cash Position | 175,191 | 225,801 | 251,134 | 318,090 | 523,668 |
| Net Cash Flow | $-75,943 | $-25,333 | $-354,043 | $-287,087 | $-81,509 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,667 | -58,028 | -158,698 | -199,969 | -8,023 |
| Capital Expenditure | -3,443 | -2,074 | -11,800 | -9,121 | -5,831 |
| Free Cash Flow | -41,110 | -60,102 | -170,498 | -209,090 | -13,854 |